The selection process can rely on microscopy-guided micromanipulation or automated cell-handling systems. In either case, researchers identify a target within a mixed population, use a micropipette or related tool to capture it, and transfer it separately. The distinction lies in how target recognition and handling are performed, while both approaches support focused analysis of individual cells.
Tumors can contain cells with different genomic, transcriptomic, phenotypic, or drug-response characteristics. Bulk assays combine these populations, which can obscure uncommon or contrasting cellular behaviors. Examining separated cells instead allows researchers to associate specific properties with individual cells, providing a clearer view of heterogeneity and clonal variation within a tumor sample.
An isolated cell can be directed toward culture or molecular testing, depending on the research objective. Molecular analyses may examine genomic or transcriptomic characteristics, while other evaluations can focus on phenotype or drug response. These measurements help connect the properties of a single cell with disease progression or treatment sensitivity rather than averaging signals across the entire population.
A typical workflow begins with a mixed cell population and identification of a target cell using microscopy or an automated handling system. The selected cell is captured with a micropipette or related tool, transferred away from the original population, and deposited into a separate container. That isolated material can then undergo culture or molecular testing.
Single Cell Picking is particularly useful when a cancer sample contains rare cell populations or substantial clonal variation. Separating cells makes it possible to examine less abundant groups that may be difficult to interpret in bulk measurements. The approach therefore supports focused studies of tumor heterogeneity and comparisons among individual cells within the same broader sample.
After separation, individual cancer cells can support phenotypic or drug-response analyses. Comparing these results across isolated cells can reveal variation in treatment sensitivity that a population-level measurement might conceal. When combined with genomic or transcriptomic information, the findings can help relate cellular characteristics to differences in response and provide a more resolved view of cancer behavior.